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Abstract: The objective of this study was to test the hypothesis that the effect of a high-fat 
meal (HFm) on plasma lipid-soluble antioxidants and biomarkers of vascular oxidative stress 
and inﬂ  ammation would be attenuated by short-term lycopene supplementation in young healthy 
subjects. Following restriction of lycopene-containing foods for 1-wk (LYr), blood was collected 
in a fasting state and 3 h after a HFm and a low-fat meal (LFm) in N = 18 men aged 23 ± 2 years, 
and after a HFm only in N = 9 women aged 23 ± 1 years. Blood was also sampled pre- and 
post-meals following 1-wk of 80 mg/day lycopene supplementation (LYs) under continued 
dietary LYr. In the fasting state, LYs compared with LYr not only evoked a  2-fold increase 
in plasma lycopene but also increased plasma β-carotene and α-tocopherol (p   0.01), though 
LYs did not affect plasma nitrate/nitrite (biomarker of nitric oxide), malondialdehyde (biomarker 
of lipid oxidative stress), vascular- and intercellular-adhesion molecules or C-reactive protein 
(biomarkers of inﬂ  ammation). Contrary to the hypothesis, the HFm-induced dyslipidemic state 
did not affect plasma malondialdehyde, C-reactive protein, or adhesion molecules in either LYr 
or LYs. Both the HFm and LFm were associated with decreases in the nitric oxide metabolites 
nitrate/nitrite and lipid-soluble antioxidants (p   0.05). The data revealed that 1-wk of LYs 
increased plasma lycopene, β-carotene, and α-tocopherol yet despite these marked changes to the 
plasma lipid-soluble antioxidant pool, biomarkers of vascular oxidative stress and inﬂ  ammation 
were unaffected in the fasted state as well as during dyslipidemia induced by a HFm in young 
healthy subjects.
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Introduction
Lycopene is a highly unsaturated acyclic carotenoid found predominantly in tomato 
products (Clinton 1998). This lipophilic compound is transported in the blood by lipo-
proteins and accumulates in many human tissues including the vasculature (Suarna et al 
1995; Stahl and Sies 1996). Recent epidemiological studies have strongly associated 
lycopene with reduced carotid intima-media thickness and lower incidences of myocar-
dial infarction, ischemic heart disease, and stroke (Kohlmeier et al 1997; Gianetti et al 
2002; Rissanen et al 2002, 2003). Accordingly, laboratory experiments have begun to 
investigate the role of lycopene on the health of the cardiovascular system.
Lycopene is a potent chemical antioxidant shown to quench reactive oxygen species 
in vitro (Bohm et al 1995) and to decrease blood lipid biomarkers of oxidative stress 
in vivo (Agarwal and Rao 1998; Rao and Agarwal 1998). Cell culture experiments have 
established that lycopene can inhibit the destruction of nitric oxide by superoxide anion 
(Panasenko et al 2000) and attenuate inﬂ  ammatory cytokine-stimulated endothelial 
cell adhesion molecule expression and monocyte-endothelial interactions (Martin et al Vascular Health and Risk Management 2008:4(1) 214
Denniss et al
2000). Moreover, a study in mice reported that lyophilized 
tomato lycopene supplementation protected against 
endothelial vasomotor dysfunction developed in response to 
a 4 month atherogenic high-fat diet (Suganuma and Inakuma 
1999). Interestingly, even in the ﬁ  rst hours after a single 
high-fat meal consumed by middle-aged healthy, nondiabetic 
humans aged 35–55 years a transient dyslipidemia has been 
associated with an increase in blood lipid biomarkers of 
oxidative stress and inﬂ  ammation (Anderson et al 2001; Bae 
et al 2001; Ceriello et al 2002, 2004; Nappo et al 2002) and 
a decrease in endothelial nitric oxide-mediated vasomotor 
function (Vogel et al 1997; Anderson et al 2001; Bae et al 
2001; Ceriello et al 2002), while these effects may be 
reversed with various antioxidant compounds (Nappo et al 
2002; Carroll and Schade 2003; Esposito et al 2003; Plotnick 
et al 2003). In comparison, studies investigating postprandial 
effects in younger healthy subjects aged 20–35 years have 
found that high-fat meal-induced transient dyslipidemia may 
result in impaired endothelial vasomotor function either 
with (van Oostrom et al 2003; Tsai et al 2004) or without 
(Schinkovitz et al 2001; Bae et al 2003) an associated 
increase in oxidative stress and/or inﬂ  ammatory markers. 
Because vascular cell phenotype/function (Widlansky et al 
2003), oxidative stress and inﬂ  ammation (Hansson 2001; 
Stocker and Keaney Jr. 2004), and the postprandial state 
(de Koning and Rabelink 2002) have emerged as important 
considerations for understanding the physiopathology of early 
cardiovascular dysfunction in time leading to disease, further 
investigation into the role of lycopene supplementation might 
reveal a mechanistic basis for the epidemiological association 
between lycopene and cardiovascular protection.
The purpose of the present study was to determine the 
effect of short-term lycopene supplementation and postpran-
dial dyslipidemia induced by a single ‘fast food’ high-fat 
meal on plasma lipid-soluble antioxidants and biomarkers of 
vascular oxidative stress and inﬂ  ammation in healthy young 
subjects not yet complicated by cardiovascular dysfunction 
or overt disease. It was hypothesized that by requesting our 
subjects to eliminate lycopene-containing foods for 1-wk 
then providing them with a pure lycopene extract for 1-wk 
while maintaining the restriction on lycopene-containing 
foods we might be able to elevate plasma lycopene in isola-
tion, and that this would be associated with an increase in 
plasma biomarkers of endothelial nitric oxide production 
and a decrease in vascular oxidative stress and inﬂ  ammation. 
Furthermore, it was hypothesized that ingesting a high-fat 
meal (HFm) following lycopene-containing food restriction 
would decrease plasma biomarkers of endothelial nitric 
oxide production and increase vascular oxidative stress and 
inﬂ  ammation, and that these effects would be mitigated by 
antioxidant lycopene supplementation.
Materials and methods
Subjects
Eighteen healthy men aged 23 (SD 2) years (range, 18–26 
years) and nine healthy women aged 23 (SD 1) years (range, 
21–24 years) with a body mass index between 20–30 kg/m2 
volunteered for this study. Entry criteria speciﬁ  ed during 
recruitment, which was done by displaying subject recruit-
ment ﬂ  yers about the university campus, included nontobacco 
users with no family history of premature cardiovascular 
disease and an absence of diagnosed hypertension, dyslip-
idemia, and diabetes mellitus. At the time of the ﬁ  rst set 
of experiments, four of the women were in the early luteal 
phase (day 17–20), four were in the late luteal phase (day 
26–28), and one was in the early follicular phase (day 5; 
menses) of the ovarian cycle. All subjects were regularly 
physically active but untrained, performing at least 1-h of 
aerobic exercise most days of the week, and self-reported 
having a relatively healthy, balanced diet that was low in 
(but not exclusive of) fast-food intake. They took no medi-
cations, including multivitamin/antioxidant supplements, 
for at least one month prior to the study, and they abstained 
from alcohol, caffeine, and formal exercise for at least 24-h 
before each laboratory session. The study was approved by 
the Ofﬁ  ce of Research Ethics at the University of Waterloo 
and subjects gave informed written consent.
Study design
One week prior to the commencement of the ﬁ  rst set of 
experiments, subjects were familiarized with the study 
design and habitual fasting blood samples were collected 
from the antecubital vein by venipuncture into vacutainer 
tubes containing either heparin, EDTA, or no anticoagulant 
(Becton Dickinson, Franklin Lakes, NJ, USA). Subjects 
were instructed on which foods contained lycopene and told 
to avoid these foods, and any dishes containing these foods, 
throughout the entire duration of the study while otherwise 
maintaining their habitual diet as best they could. The list 
of food items to be avoided (including juices, sauces, soups, 
mixed dishes etc) included apricots, grapefruit, guava, 
papaya, tomato, and watermelon. Subjects returned to the 
laboratory after dietary restriction of lycopene-containing 
foods for 1-wk (LYr) for the ﬁ  rst phase of testing. In the 
men, blood samples were collected in the fasting state and 
then again 3-h after ingesting either a ‘fast food’ high-fat Vascular Health and Risk Management 2008:4(1) 215
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meal (HFm) or an isocaloric low-fat meal (LFm). The time 
point of 3-h for blood sampling following ingestion of the 
meals was chosen based on previous studies demonstrating 
that plasma dyslipidemia, biomarkers of vascular oxidative 
stress and inﬂ  ammation, and endothelial cell dysfunction 
in healthy subjects increased to a peak at 2–4 hours after 
ingestion of a HFm (Marchesi et al 2000; Ceriello et al 2002, 
2004; Tsai et al 2004). The HFm and the LFm were provided 
on two consecutive days with the order counterbalanced so 
that 9 men received the HFm on the ﬁ  rst day and the LFm on 
the second day and vice versa for the other 9 men. The HFm 
(49% total fat) consisted of an Egg McMufﬁ  n®, a Sausage 
McMufﬁ  n®, two hash brown patties, and 250 ml of 2% milk 
(1107 kcal total energy containing 100 g carbohydrates, 44 g 
protein, 60 g fat including 24 g saturated fat and 4 g trans fat, 
and 308 mg cholesterol; McDonald’s Corporation, Canada). 
This HFm was commercially prepared and selected because 
it contained the same foods shown previously in middle-aged 
subjects to cause dyslipidemia and impaired endothelial func-
tion that was reversed by antioxidant supplementation (Vogel 
et al 1997; Plotnick et al 2003); however, it is impossible to 
state that the meal content was identical since there might 
be differences in suppliers of meal components and food 
preparation that could cause different responses (Vogel et al 
1997; Williams et al 1999). The LFm (2% total fat) consisted 
of 200 g of frosted ﬂ  akes cereal, 580 ml of skimmed milk, 
and 460 ml of a ﬂ  avored sugar drink (1110 kcal total energy 
containing 243 g carbohydrates, 28 g protein, 2 g fat, and 
0 mg cholesterol). For the female subjects, only the HFm was 
studied. Our female subjects were recruited into the study 
after we studied the men and compared their blood biochemi-
cal responses to the HFm and the LFm (see Blood processing 
and biochemical analyses, Methods below), and since the 
HFm did not provoke responses in blood antioxidants or bio-
markers of endothelial health that differed substantially from 
the LFm responses (see Results), the focus of investigation in 
the females was narrowed to the HFm postprandial state and 
to a select range of biochemical responses. Blood samples 
were collected from the women in the fasting state and then 
again 3-h after ingesting a similar ‘fast food’ HFm that was 
slightly lower in total energy content in an attempt to account 
for differences in average daily caloric intake between men 
and women. This HFm (48% total fat) consisted of an Egg 
McMufﬁ  n®, a Sausage McMufﬁ  n®, one hash brown patty, 
and 250 ml of 2% milk (957 kcal total energy containing 84 g 
carbohydrates, 42 g protein, 51 g fat including 20 g saturated 
fat and 3 g trans fat, and 303 mg cholesterol; McDonald’s 
Corporation, Canada). During the 3-h between when the 
meals were consumed and the post-meal blood sampling, 
subjects were allowed to leave the laboratory unsupervised 
with the request to remain as sedentary as possible and not 
to eat. Following an additional 1-wk during which subjects 
continued to restrict lycopene from their diet but took a 
80 mg/day lycopene extract supplement (LYs – 4 × 10 mg 
capsules taken with food in the morning and the evening; 
Lyc-O-Mato, Herbal Select Company, Guelph, Canada), 
additional blood samples were collected 12-h following the 
last dose of lycopene in a fasting state and 3-h after ingestion 
of the same meals outlined above. An 80 mg daily dosage 
of lycopene extract was chosen based on previous studies 
demonstrating that supplementation with 96.5% pure lyco-
pene tomato oleoresin (equivalent to 75 mg/day of lycopene) 
daily for 1-wk following LYr resulted in a  2-fold increase 
in serum lycopene concentration and an ∼20%–25% decrease 
in serum lipid biomarkers of oxidative stress (Agarwal and 
Rao 1998; Rao and Agarwal 1998). Subjects recorded all 
food and drink consumed daily in diet logs throughout the 
entire study.
Blood processing and biochemical 
analyses
Within 30-min of each venipuncture sampling, blood was 
centrifuged and the resultant serum and plasma supernatants 
were transferred to labeled microtubes and frozen at –80 °C. 
All quantiﬁ  cation of processed blood described below was 
performed within 6- to 8-wks of blood sampling. Blood 
lycopene, β-carotene, α-tocopherol, retinol, cholesterol, 
triacylglycerol, glucose, insulin, and nitrate/nitrite-derived 
NO·concentrations were determined from all men and 
women across all conditions. Employing a HPLC procedure 
developed by Su and colleagues (1999) (Waters, Milford 
MA, Model 2695 solvent delivery pump and autosampler, 
Model 2996 photodiode array detector, 250 × 4.6 mm 
Spherisorb ODS2 reversed phase C18 column with 5 µm 
particle diameter and C18 10 × 4.6 mm guard column), the 
lipid-soluble antioxidants lycopene (trans + cis), β-carotene, 
α-tocopherol, and retinol were quantiﬁ  ed in heparinized 
plasma samples (HPLC-grade solvents/reagents from Fisher 
Scientiﬁ  c, Whitby, Canada;  95% pure standards from 
Sigma Chemicals, St. Louis MO). Total cholesterol, HDL 
cholesterol, and triacylglycerol were quantiﬁ  ed in heparinized 
plasma using standard enzymatic reagent assay kits (Catalog 
No. 225-28, 200-26, and 210-75 respectively; Diagnostic 
Chemicals Ltd., Charlottetown, Canada) and a microplate 
spectrophotometer (SPECTRAmax PLUS 384, Sunnyvale 
CA). Serum glucose was quantiﬁ  ed spectrophotometrically Vascular Health and Risk Management 2008:4(1) 216
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(UV-160U, Shimadzu Corp., Tokyo, Japan) according to 
standard enzymatic methods (Catalog No. 510-6, D-3252, 
and 635-100 from Sigma Chemicals, St. Louis MO), and a 
solid-phase Coat-a-Count®125I radioimmunoassay kit (Catalog 
No. TKIN5 from Diagnostic Products Corp., Los Angeles 
CA) and gamma counter (Beckman Gamma 5500, Irvine CA) 
were used to quantify serum insulin. Plasma nitrate/nitrite, 
taken as a biomarker of total nitric oxide metabolites, was 
determined by a nitric oxide analyzer (Model 280i, Sievers 
Instruments, Inc., Boulder CO) to quantify nitric oxide gas 
generated from the reaction between plasma nitrate/nitrite 
and heated vanadium (III) chloride (high purity sodium 
nitrate from BioShop Inc., Burlington, Canada; HPLC-grade 
ethanol from Fisher Chemicals, Fairlawn NJ; vanadium (III) 
chloride from Sigma-Aldrich, St. Louis MO). The blood 
lipid biomarker of oxidative stress malondialdehyde was 
determined in samples from the ﬁ  rst 10 men studied across 
all conditions. Prior to quantiﬁ  cation, malondialdehyde in 
EDTA plasma samples was hydrolyzed/derivatized and 
extracted according to methods adopted from Sim and 
colleagues (2003) and Rodriguez and colleagues (2003) 
respectively (NaOH from Fisher Scientiﬁ  c, Whitby, Canada; 
70% perchloric acid from BDH, Toronto, Canada; 97% 
pure 2,4-dinitrophenylhydrazine from Sigma Chemicals, 
St. Louis MO; Amberlite® XAD®-2 from Supelco, 
Bellefonte PA), using 95% pure acid hydrolyzed 1,1,3,3-
tetraethoxypropane as the malondialdehyde standard 
and  99% pure benzaldehyde as an internal standard (Sigma 
Chemicals, St. Louis MO). The derivatized malondialdehyde 
extract was then quantiﬁ  ed by employing a HPLC procedure 
modiﬁ  ed from Pilz et al (Pilz et al 2000) (250 × 4.6 mm 
Spherisorb ODS2 reversed phase C18 column with 5 µm 
particle diameter and C18 10 × 4.6 mm guard column 
from Waters, Milford MA; HPLC-grade solvents/reagents 
from Fisher Scientiﬁ  c, Whitby, Canada). Soluble intercellular 
adhesion molecule-1 (sICAM-1) and vascular cell adhesion 
molecule-1 (sVCAM-1), and high-sensitivity C-reactive 
protein (CRP) are blood biomarkers of inﬂ  ammation and have 
been shown to predict increased risk of future cardiovascular 
disease in apparently healthy individuals (Ridker et al 1998; 
Koenig et al 1999). From the blood of the remaining 8 men 
whose plasma malondialdehyde concentration was not 
determined, serum sICAM-1, sVCAM-1, and CRP were 
quantiﬁ  ed following LYr and LYs both in a fasting state and 
3-h after ingesting the HFm using standard enzyme–linked 
immunosorbent assay kits (sICAM-1 Catalog No. BBE 1B 
and sVCAM-1 Catalog No. BBE 3, R&D Systems Inc., 
Minneapolis MN; CRP Catalog No. 2210, Life Diagnostics, 
West Chester PA) and a microplate spectrophotometer 
(SPECTRAmax PLUS 384, Sunnyvale CA). This decision 
was made based on considering the limited quantity of 
blood that remained to be analyzed, the fact that plasma 
malondialdehyde was found to be unchanged across all 
conditions in the ﬁ  rst 10 men studied (see Results), and 
the desire to also have blood biomarkers of inﬂ  ammation 
following LYs and in the postprandial state, especially after 
the HFm where inﬂ  ammatory biomarker changes are most 
probable.
Statistical analyses
All data are presented as means with standard deviations 
(SD). Statistical analyses were performed using the Statistical 
Analysis Software program (SAS Institute, Cary NC). The 
effects of lycopene manipulation (Habitual, LYr, LYs) and 
the HFm (fasting, 3-h post) on blood biochemical variables 
in men or in women were evaluated by two-way repeated-
measures ANOVA. Similarly, the effects of lycopene 
manipulation and the LFm on blood biochemical variables 
in men were evaluated by two-way repeated-measures 
ANOVA. Comparisons of men vs women were tested for 
LYr and LYs on fasting biochemical variables by repeated-
measures ANOVA. A probability of 0.05 was accepted as 
statistically signiﬁ  cant, with any main effects and interactions 
in the above ANOVAs reaching this probability further 
evaluated by least squares difference post hoc testing.
Results
Effects of LYr and LYs on blood 
lipid-soluble antioxidants
Habitual plasma lycopene [men: 0.93 (SD 0.25) µmol/L; 
women: 0.49 (SD 0.18) µmol/L; Figure 1A] and retinol [men: 
3.57 (SD 0.68) µmol/L; women: 2.82 (SD 1.11) µmol/L; 
Figure 1D] were signiﬁ  cantly lower in women compared 
with men [p   0.01 and p = 0.03 respectively] whereas 
plasma β-carotene [men: 0.29 (SD 0.20) µmol/L; women: 
0.34 (SD 0.24) µmol/L; Figure 1B] and α-tocopherol [men: 
16.61 (SD 5.13) µmol/L; women: 15.59 (SD 3.93) µmol/L; 
Figure 1C] were not statistically signiﬁ  cantly different. 
One week of LYr decreased plasma lycopene by 39%–48% 
in both men and women compared with habitual diet 
[p   0.01], and a subsequent 1-wk of LYs increased plasma 
lycopene by 114% in men and by a smaller but still marked 
88% in women [men and women both p   0.01; Figure 1A]. 
Neither LYr nor LYs affected plasma retinol [Figure 1D]. 
Lycopene restriction did not affect plasma β-carotene in men Vascular Health and Risk Management 2008:4(1) 217
Lycopene, acute dyslipidemia, and blood biomarkers
compared to habitual food intake but was associated with a 
31% decrease in women [p = 0.02; Figure 1B]. In contrast, 
with LYr there was an 8% decrease in plasma α-tocopherol 
in men [p   0.01] but not in women compared with habitual 
food intake [Figure 1C]. Lycopene supplementation was 
associated with a 104% increase in plasma β-carotene in men 
and a smaller (p = 0.03) but still signiﬁ  cant 31% increase in 
women [Figure 1B], whereas plasma α-tocopherol increased 
similarly in both men and women following LYs [men: 21%; 
women: 24%; p   0.01; Figure 1C]. HPLC analysis of the 
supplement veriﬁ  ed a composition of  98% lycopene with 
no trace of α-tocopherol or β-carotene, and analysis of the 
diet logs using Diet Analysis Plus software [V5.1, Wad-
sworth Publishing Co., Salem OR] indicated no detectable 
difference in the intake of Vitamin A retinol equivalents or 
Vitamin E α-tocopherol equivalents, or other micro- and 
macronutrients, between LYr and LYs weeks of the study 
[data not shown].
Diet log analysis also indicated that the average 
diet consumed during the study consisted of a 52:18:30 
carbohydrate-to-protein-to-fat ratio with total energy and 
macronutrient intake within 80%–120% of Dietary Reference 
Intake guidelines for their age and sex (ie, total energy, 89%; 
carbohydrates, 81%; protein, 119%; total fat, 89%; saturated 
fat, 86%; cholesterol, 108%) except dietary ﬁ  ber (61%), sug-
gesting that our subjects ate a relatively healthy, balanced diet 
throughout the LYr and LYs experimental weeks when they 
were asked to maintain their general habitual diet but eliminate 
all lycopene-containing foods. We do not have data for the 
general habitual diets of our subjects; however, all subjects 
reported that they maintained the same dietary patterns with 
the exception of avoiding lycopene-containing foods during 
the test period.
Effect of LYs on other blood biochemical 
characteristics
Blood lipid, glucose, insulin, nitrate/nitrite, malondialdehyde, 
sICAM, sVCAM, and CRP concentrations are reported in 
Table 1. These measures were not different between LYr 
Figure 1 Plasma concentration of lycopene (A), β-carotene (B), α-tocopherol (C), and retinol (D) in men (n = 18) and women (n = 9) after a habitual diet (H) and after a 
1-wk lycopene-containing food restricted diet (LYr) followed by 1-wk of supplementation with a 80 mg/day >98% pure lycopene (LYs) under continued LYr in both a fasting 
state and 3-h post high-fat meal (HFm) and low-fat meal (LFm) in men and 3-h post HFm in women. Values are means (SD). p < 0.05.
adenotes a signiﬁ  cant effect of either the LYr or LYs condition compared to the H condition, and bdenotes a signiﬁ  cant effect of the LYs condition compared to the LYr 
condition. There were no signiﬁ  cant interactions. See Results for details of main effect sex and meal statistical comparisons.Vascular Health and Risk Management 2008:4(1) 218
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Table 1 Biochemical characteristics measured in blood in relation to lycopene manipulation and meals
MEN (N = 18)  n  LYr    LYs     Meal effect  LYs effect
    Fasting  3-h post  Fasting  3-h post  p value  p value
HIGH-FAT MEAL                     
Total cholesterol,   18  4.9  4.8   4.7  4.5  0.37  0.12
mmol/l    (SD 1.7)  (SD 1.7)  (SD 1.7)  (SD 1.7)   
HDL cholesterol   18  1.8   1.5   1.6  1.5   0.01 0.1
mmol/l    (SD 0.8)  (SD 0.4)  (SD 0.8)  (SD 0.8)   
Triacylglycerol,   18  0.8 1.6  1.0 1.9  0.01 0.16
mmol/l    (SD 0.4)  (SD 0.8)  (SD 0.8)  (SD 1.2)   
Glucose,  mmol/l 18  5.2 5.4  5.3 5.3 0.51  0.88
    (SD 0.8)  (SD 0.8)  (SD 1.2)  (SD 1.2)   
Insulin, ρmol/l  18  49 108  46 95  0.01 0.29
    (SD 17)   (SD 59)  (SD 17)  (SD 55)   
Nitrate/nitrite, µmol/l  18  35 31  32 29  0.01 0.29
    (SD 17)   (SD 13)  (SD 17)  (SD 17)   
Malondialdehyde,   10  7.5   7.8   7.7  7.8  0.62  0.81
µmol/l    (SD 2.2)  (SD 2.8)  (SD 2.2)  (SD 2.2)   
sICAM-1, ng/ml  8  178   181  220  168  0.29  0.4
    (SD 40)   (SD 42)  (SD 99)  (SD 51)   
sVCAM-1, ng/ml  8  441   416  413  392  0.11  0.57
    (SD 124)  (SD 144)  (SD 133)  (SD 141)   
CRP, mg/l  8  0.41   0.61  0.37  0.46  0.25  0.68
    (SD 0.35)  (SD 0.80)  (SD 0.45)  (SD 0.69)   
LOW-FAT MEAL                     
Total  cholesterol,    18  4.6 4.7  4.5 4.4 0.96  0.25
mmol/l    (SD 1.7)  (SD 1.3)  (SD 1.3)  (SD 1.3)   
HDL cholesterol   18  1.5  1.5   1.4   1.3  0.31  0.1
mmol/l    (SD 0.4)  (SD 0.4)  (SD 0.4)  (SD 0.4)   
Triacylglycerol,   18  0.8  0.9  0.8   0.9  0.27  0.78
mmol/l    (SD 0.4)  (SD 0.4)  (SD 0.4)  (SD 0.4)   
Glucose, mmol/l  18  5.1   4.6   5.2  4.9  0.01  0.2
    (SD 0.8)  (SD 0.8)  (SD 0.8)  (SD 1.3)   
Insulin, ρmol/l  18  47  173   48   169   0.01 0.93
    (SD 17)  (SD 93)  (SD 21)  (SD 106)   
Nitrate/nitrite, µmol/l  18  37   30   39  31    0.01 0.8
    (SD 21)  (SD 13)  (SD 32)  (SD 25)   
Malondialdehyde,   10  7.9   7.1  8.5   7.7   0.11  0.1
µmol/l    (SD 2.2)  (SD 1.9)  (SD 2.5)  (SD 1.9)   
WOMEN (N = 9)                     
HIGH-FAT MEAL                     
Total cholesterol,   9  4.6   5.1  4.9   4.6   0.48  0.44
mmol/l    (SD 0.9)  (SD 0.9)  (SD 0.9)  (SD 0.9)   
HDL, cholesterol   9  2.0  1.8  2.0   1.8   0.07  0.89
mmol/l    (SD 0.9)  (SD 0.6)  (SD 0.9)  (SD 0.6)   
Triacylglycerol,   9  0.8   1.5   0.8   1.3    0.01 0.16
mmol/l    (SD 0.3)  (SD 0.6)  (SD 0.3)  (SD 0.3)   
Glucose, mmol/l  9  4.6  4.6  5.3   5.3   0.95  <0.01
    (SD 0.3)  (SD 0.6)  (SD 0.6)  (SD 0.6)   
Insulin, ρmol/l  9  77   208   57  148    0.01 0.08
    (SD 60)  (SD 117)  (SD 36)  (SD 57)   
Nitrate/nitrite, µmol/l  9  43  29   38   29    0.01 0.68
    (SD 27)  (SD 12)  (SD 15)  (SD 9)   
Notes: Values [means (SD)] were measured after a 1-wk lycopene-containing food restricted diet (LYr) followed by 1-wk of supplementation with a 80 mg/day >98% pure 
lycopene (LYs) under continued LYr in both a fasting state and 3-h post high-fat meal and low-fat meal in men and 3-h post high-fat meal in women. Probability values for 
the main effects of LYs and Meal are presented. There were no signiﬁ  cant interactions. 
Abbreviations: sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, vascular cell adhesion molecule-1; CRP, high-sensitivity C-reactive protein.Vascular Health and Risk Management 2008:4(1) 219
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and LYs for the men, nor did they differ in women with 
the exception of glucose which was signiﬁ  cantly higher 
following LYs.
Effect of high-fat and low-fat meal
on blood lipid-soluble antioxidants
In men, the HFm was associated with a 3%–4% decrease 
in each of plasma lycopene, β-carotene, and α-tocopherol 
(Figure 1, p = 0.03). After the LFm, plasma α-tocopherol was 
decreased by 3% in men (p = 0.03) whereas plasma lycopene 
and β-carotene were unaffected. In women, the HFm was 
associated with a 17%–20% decrease in plasma lycopene 
and β-carotene (p = 0.01), whereas plasma α-tocopherol 
was unaffected. Plasma retinol in men and women was 
unaffected following the meals. There were no signiﬁ  cant 
interactions between Meal and LYs on blood lipid-soluble 
antioxidants.
Effect of high-fat and low-fat meals on 
other blood biochemical characteristics
Plasma triacylglycerol was increased 107% in men and 88% 
in women following the HFm but was no different following 
the LFm in men (Table 1). Plasma HDL cholesterol although 
unchanged after the LFm was 9% decreased subsequent to the 
HFm in men, and the decrease following the HFm in women 
nearly reached the criterion for signiﬁ  cance. There was no 
effect of the HFm or LFm in men or the HFm in women on 
plasma total cholesterol. Similarly, plasma malondialdehyde 
following the LFm and plasma malondialdehyde and serum 
sICAM-1, sVCAM-1, CRP following the HFm were unaf-
fected in men (Table 1). Serum insulin was 260% increased 
and serum glucose was decreased 7% after the LFm in men, 
and in response to the HFm serum insulin was increased 
115% whereas serum glucose was unchanged. In women, 
serum insulin was increased 165% and serum glucose 
was unchanged after the HFm. Plasma nitrate/nitrite was 
decreased 19% following the LFm in men and was decreased 
10% in men and 25% in women following the HFm. There 
were no signiﬁ  cant interactions between Meal and LYs on 
any of these other blood biochemical characteristics.
Discussion
In the current study, we set out to test the hypothesis that LYs 
would increase plasma lycopene and the resulting improve-
ment in lipid-soluble antioxidant status would reduce oxida-
tive stress and inﬂ  ammatory biomarkers and attenuate the 
responses of these biomarkers to a HFm. Consistent with our 
hypothesis, we did ﬁ  nd an elevation of plasma lycopene but 
this was accompanied by an unexpected increase in plasma 
β-carotene and α-tocopherol while there were no changes in 
fasting blood biomarkers of oxidative stress and inﬂ  amma-
tion. Another important ﬁ  nding of the current research was 
that the vascular system of young healthy men and women 
appeared to be capable of coping with the dyslipidemic 
state induced by the HFm even during the phase of LYr as 
well as following LYs so that biomarkers of oxidative stress 
and inﬂ  ammation were unaffected. This observation was in 
contrast to our hypothesis and to a number of, but not all 
(Schinkovitz et al 2001; Bae et al 2003), previous studies in 
subjects both young (van Oostrom et al 2003; Tsai et al 2004; 
Tushuizen et al 2006) and middle-aged (Anderson et al 2001; 
Bae et al 2001; Nappo et al 2002; Ceriello et al 2002, 2004) 
upon which the hypothesis was based.
Plasma lipid-soluble antioxidants, 
metabolites, and biomarkers
The LYr phase in the present study caused plasma lycopene 
to be reduced by approximately one-half suggesting that our 
subjects habitually ate foods containing this carotenoid. As 
anticipated (Agarwal and Rao 1998; Paetau et al 1998; Rao 
and Agarwal 1998; Tyssandier et al 2004) LYs dramatically 
increased plasma lycopene, though it was not anticipated with 
our experimental design that supplementation with pure lyco-
pene extract while under continued LYr would be associated 
with the observed signiﬁ  cant increases in plasma β-carotene 
and α-tocopherol. In contrast, plasma retinol was unaffected 
in response to LYr and LYs, perhaps due to its regulation by 
the liver (Ross and Zolfaghari 2004). At present, we have 
no explanation for the increases in plasma β-carotene and 
α-tocopherol with LYs. Analysis of the diet logs did not show 
an increase in foods containing these compounds from the 
ﬁ  rst to the second week of LYr, and we conﬁ  rmed the supple-
ments to be >98% lycopene with no trace of α-tocopherol or 
β-carotene. Furthermore the increase in these lipid-soluble 
antioxidants cannot be explained by a change in plasma total 
lipids, as cholesterol and triacylglycerol concentrations were 
unaffected by LYs.
The habitual plasma lipid-soluble antioxidants measured 
and the sex differences observed in the current study are 
well within the considerable variability established for and 
between healthy men and women in recent large-scale studies 
(Olmedilla et al 2001; Al Delaimy et al 2005). In response to 
LYs, plasma α-tocopherol was increased similarly in our men 
and women but lycopene and β-carotene in women were only 
increased to a level matching their habitual concentrations 
whereas in men they were increased to a level exceeding their Vascular Health and Risk Management 2008:4(1) 220
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habitual concentrations. Interestingly, these data suggest that 
the women may have reached a biological limit of plasma 
lycopene by way of their habitual food intake whereas the 
men did not. Indeed, there is precedent for the concept of a 
biological limit of plasma lycopene in response to supple-
mentation as evidenced by the fact that serum lycopene in 
humans has been shown to increase in a dose-independent 
manner (Agarwal and Rao 1998; Rao and Agarwal 1998). 
What might determine this biological limit of plasma carot-
enoid concentration and whether those determinants might 
be affected by sex remains to be elucidated.
Blood lipids, glucose, and insulin were unaffected by LYs 
in the present study, with the exception of an increase in glu-
cose in the women. LYs did not affect any of the biomarkers 
of vascular oxidative stress or inﬂ  ammation. In slightly older 
healthy men and women aged 25–40 years, 1-wk lycopene-
free diet decreased serum lycopene 50% and increased blood 
lipid biomarkers of oxidative stress 25% (Rao and Agarwal 
1998), while supplementation with lycopene-containing 
foods doubled serum lycopene and reduced lipid biomarkers 
of oxidative stress  20% (Agarwal and Rao 1998; Rao and 
Agarwal 1998). Similar to our ﬁ  ndings, Briviba and col-
leagues (2004) recently showed that in healthy young men 
the plasma lipid oxidation metabolite malondialdehyde was 
unaffected by 2-wk tomato juice lycopene supplementation 
compared to a low-carotenoid diet. Plotnick and colleagues 
(2003) demonstrated that 4-wk phytonutrient supplementa-
tion increased plasma nitrate/nitrite by ∼45% in healthy 
middle-aged men and women; however in the current study 
we did not to ﬁ  nd a difference in plasma nitrate/nitrite 
following LYs. Epidemiological data across the general 
population suggested that plasma lycopene and β-carotene 
were inversely related to sICAM-1 and CRP respectively 
(Herpen-Broekmans et al 2004), but another data set from 
a mixed group of healthy and diseased individuals found, 
consistent with our results following LYs, no correlation 
(Gianetti et al 2002). Taken altogether, the current study 
suggests that our young healthy subjects did not necessarily 
rely on lycopene intake or the plasma concentrations of the 
lipid-soluble antioxidants measured in order to control their 
level of plasma oxidative stress and inﬂ  ammation. The above 
comparisons imply that the nature of the supplement (eg, 
pure extract vs antioxidant-containing foods), its duration 
of administration (eg, short-term, 1 to 2-wks vs longer-term, 
4-wks), and likely most importantly the characteristics of 
the cohorts studied (eg, age, sex, physical activity level, 
dietary habits) may be responsible for discrepancies seen in 
the previous literature.
Postprandial responses
We set out to determine the effect of LYs and postprandial 
dyslipidemia on blood lipid-soluble antioxidants and 
biomarkers of vascular oxidative stress and inﬂ  ammation 
in young healthy subjects. In the control conditions of LFm 
we found no change in plasma lipids or the oxidative stress 
marker malondialdehyde, and no effect of LYs on these 
responses. In response to the HFm plasma triacylglycerol 
increased >85% and HDL cholesterol decreased ∼10%. 
Plasma insulin was higher in females than males following 
the HFm but was still within values previously reported at 
the same time point in young healthy subjects (Raitakari et al 
2000; Koutsari et al 2004; Blendea et al 2005). Higher insulin 
in females is consistent with studies showing a tendency for 
elevated insulin in young females after a HFm (Koutsari et al 
2004) or glucose load (Flanagan et al 2006); conversely, 
some results ﬁ  nd no postprandial gender differences (Ahmed 
et al 1976). Despite a marked postprandial dyslipidemia, 
malondialdehyde, sICAM-1, sVCAM-1, and CRP in the men 
remained unchanged from the fasting state both following 
LYr and with LYs, suggesting that the HFm did not impose 
a signiﬁ  cant level of vascular oxidative stress or inﬂ  amma-
tion. Decreases in plasma lipid-soluble antioxidants and 
nitrate/nitrite observed after the HFm in our experiments, 
supported by some (Rao and Agarwal 1998; Blendea et al 
2005) but not all (Brown et al 1989; Carroll and Schade 2003) 
reports, might signify that the meal-induced dyslipidemia 
perturbed the oxidative stress-nitric oxide system, although 
plasma α-tocopherol and nitrate/nitrite were also decreased 
in men after the LFm where there was no dyslipidemia imply-
ing that a response common to both meals might have been 
responsible for the changes measured.
Our overall ﬁ  ndings suggesting little to no change in 
markers of oxidative stress and/or inﬂ  ammation with post-
prandial dyslipidemia in young healthy men and women were 
in part unexpected, especially following LYr when plasma 
lipid-soluble antioxidants were markedly reduced. Previous 
studies demonstrated that consuming a HFm increased blood 
biomarkers of oxidative stress and inﬂ  ammation not only 
in healthy middle-aged subjects (Anderson et al 2001; Bae 
et al 2001; Nappo et al 2002; Ceriello et al 2002, 2004) but 
also in subjects of a very similar age to the men and women 
of our study (van Oostrom et al 2003; Tsai et al 2004). The 
HFm was associated with endothelial vasomotor dysfunc-
tion that could be reversed with antioxidants in both cohorts 
(Bae et al 2003; Esposito et al 2003; Plotnick et al 2003). 
Consistent with our ﬁ  ndings other studies in young, healthy 
subjects reported no change in oxidative stress, inﬂ  ammation Vascular Health and Risk Management 2008:4(1) 221
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(Schinkovitz et al 2001; Bae et al 2003; Tsai et al 2004) or 
endothelial vasomotor function (Tushuizen et al 2006) after 
a single HFm. Most noteworthy, a recent study by Tushuizen 
and colleagues (2006) found that endothelium-dependent 
ﬂ  ow-mediated dilation was no different up to 4-h after a 
‘fast food’ HFm in healthy young subjects aged 20–35 yrs 
who were physically active training ∼6-h/week, whereas 
consumption of a second HFm at 4-h lead to an increase 
in blood malondialdehyde, oxidized LDL, and cellular 
microparticles, and impairment of ﬂ  ow-mediated dilation. 
In this light, considering the cohort characteristics of the 
current study (aged 18–26 yrs, regularly physically active, 
with presumably healthy, balanced diets) it is possible that 
ingestion of not just one but a subsequent HFm (Tushuizen 
et al 2006) may have been needed to overcome our subjects’ 
already robust vascular antioxidant buffering capacity and 
induce a pro-oxidative, pro-inﬂ  ammatory response leading 
to transient vascular dysfunction, whereas ingestion of only 
one HFm may be all that is necessary in older and/or possibly 
more sedentary cohorts.
Study limitations
The current study provides new information regarding the 
effect of LYs and postprandial dyslipidemia on blood bio-
chemical characteristics in humans; however, a number of 
potential limitations should be noted. First and foremost, 
from comparisons made in the Discussion of our ﬁ  ndings to 
the available data in the literature, it appears that the young, 
physically active cohort examined in the present study may 
limit the ability to generalize how blood antioxidants and bio-
markers of endothelial health respond to LYs and to a HFm. 
The possibility should also be considered that the measures of 
vascular oxidative stress and inﬂ  ammation used in the cohort of 
the present study may not have been sensitive and/or speciﬁ  c 
enough to mark any changes occurring in these aspects of 
endothelial health, and that other more appropriate biomarkers 
might have revealed signiﬁ  cant differences. In regard to the 
unanticipated increases in plasma β-carotene and α-tocopherol 
concomitant with LYs, it might have been advantageous to 
have had our subjects record their habitual diets and provide 
weekly fasting blood samples 1-month prior to the commence-
ment of the study, and provide blood samples daily throughout 
the study, as these data could have offered some insight into 
the plasma lipid-soluble antioxidant changes that occurred 
during LYr and LYs. Moreover, given that the purpose of our 
study was to determine only the short-term effects of lycopene 
manipulation, it now needs to be determined the extent to 
which young healthy subjects can control their levels of plasma 
lipid-soluble antioxidants, oxidative stress, and inﬂ  ammation 
with a more prolonged LYr and/or LYs.
Summary
It may be concluded from this study that 1-wk of LYs mark-
edly increased plasma lycopene as well as β-carotene and 
α-tocopherol; however despite these changes to the plasma 
lipid-soluble antioxidant pool, biomarkers of vascular oxi-
dative stress and inﬂ  ammation were unaffected in young, 
active men and women both in the fasted state and following 
a HFm resulting in dyslipidemia. These data suggest that our 
subjects possessed an already robust antioxidant capacity 
capable of tightly maintaining vascular homeostasis and that 
LYs provided no additional beneﬁ  t. Moreover, this study 
suggests that there are complex dynamics governing plasma 
lipid-soluble antioxidants in response to dietary supplemen-
tation and to ingesting both HFm and LFm, which merits 
future investigation as these dynamics might be involved in 
the control of vascular homeostasis.
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